AF
COGT icon

Allworth Financial’s Cogent Biosciences COGT Stock Holding History

Allworth Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3K Buy
320
+292
+1,043% +$10.8K ﹤0.01% 3366
2025
Q4 		$995 Buy
28
+24
+600% +$675 ﹤0.01% 4355
2025
Q3 		$58 Buy
+4
New +$47 ﹤0.01% 4733
2025
Q1 		– Sell
-33
Closed -$271 – 4082
2024
Q4 		$271 Sell
33
-27
-45% -$269 ﹤0.01% 3732
2024
Q3 		$648 Hold
60
– – ﹤0.01% 3359
2024
Q2 		$517 Buy
60
+27
+82% +$205 ﹤0.01% 3363
2024
Q1 		$222 Buy
+33
New +$204 ﹤0.01% 3436
2023
Q4 		– Sell
-12
Closed -$117 – 3490
2023
Q3 		$117 Buy
+12
New +$142 ﹤0.01% 3321

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Allworth Financial's COGT Position: Q1 2026 in Review

Allworth Financial increased its Cogent Biosciences (COGT) stake by 1,043% in Q1 2026, buying an estimated $10.8K and bringing the position to 320 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Allworth Financial first reported a position in COGT in Q3 2023 and has held it in 8 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Allworth Financial held 320 shares of Cogent Biosciences worth $12.3K as of Q1 2026.
  • Allworth Financial bought 292 Cogent Biosciences shares in Q1 2026, an estimated $10.8K.
  • Cogent Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3366 holding.
  • Allworth Financial first reported a position in Cogent Biosciences in Q3 2023 and has held it in 8 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.